Home Your basket
• Life after total laryngec...
   Price 8.50 €
• Giant pleomorphic adenoma...
   Price 5.50 €
• Laryngeal schwannoma: A c...
   Price 5.50 €
• Attention deficit disorde...
   Price 10.50 €
• The prevention of voice d...
   Price 10.50 €
• A survey of current wound...
   Price 5.50 €
• Possible role of biofilm ...
   Price 10.50 €
• Role and importance of pH...
   Price 12.00 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Epidermoid carcinoma of p...
   Price 10.50 €
• The sound intensity after...
   Price 10.50 €
• Assumptions in surgical t...
   Price 8.50 €
• Usefulness and limitation...
   Price 10.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Context influence on the ...
   Price 10.50 €
• Congenital cyst and fistu...
   Price 10.50 €
• The input of autogenous g...
   Price 10.50 €
• Treatment and rehabilitat...
   Price 10.50 €
• External otitis...
   Price 8.50 €
• Clinical signs and correl...
   Price 10.50 €
• Parathyroid carcinoma: di...
   Price 5.50 €
• Ruptured pexis after supr...
   Price 10.50 €
• Endoscopic endonasal surg...
   Price 8.50 €
• Pharyngolaryngectomy for ...
   Price 10.50 €
• Hygiene and sterilisation...
   Price 10.50 €
• Reverse phonation: Pathol...
   Price 8.50 €
• Exophthalmos arising from...
   Price 10.50 €
• Osteointegrated cranio-fa...
   Price 10.50 €
• A rare and unusual cause ...
   Price 8.50 €
• Cranial fasciitis of chil...
   Price 8.50 €

Total Order 272.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 4 - 2011 o

CANCER

Total pharyngolayngectomy in the 21st century: Indica­tions, oncologic and functional outcomes


Authors : Agopian B, Dassonville O, Chamorey E, Poissonnet G, Pierre S, Peyrade F, Hebert C, Benezery K, Viel D, Sudaka A, Vallicioni J, Demard F, Santini J, Bozec A. (Nice)

Ref. : Rev Laryngol Otol Rhinol. 2011;132,4:209-214.

Article published in french
Downloadable PDF document french



Summary : Introduction: The development of laryngeal preservation protocols has considerably modified the indications for total (pharyngo-)laryngectomy (TPL). The objectives of our study are to analyze the current indications for TPL and to evaluate the oncologic and functional outcomes after TPL and their predictive factors. Methods: All patients who underwent TPL for squamous cell carcinoma of the larynx or hypopharynx, at our institution, between 2000 and 2009, were included in this retrospective study. Predictive factors of oncologic and functio­nal outcomes were assessed in univariate and multivariate analyzes. Results: A total of 130 patients were enrolled in our study including 119 men and 11 women, with a mean age of 65.9 years. TPL was realized for salvage in 65 patients. Extra-laryngeal tumor extension (n= 42) was the main indication for TPL in the 65 remaining patients. Overall survival was 49 and 41% at 3 and 5 years respectively. In multivariate analysis, prima­ry tumor site (hypopharynx in comparison to larynx; p= 0.04) has a significant pejorative impact on overall survi­val. Oral alimentation (no enteral nutrition) was recovered successfully by 94% of the patients. In multivariate analysis, primary tumor site (hypopharynx) has a significant pejorative impact on functional results (deglutition: p< 0.0001; phona­tion: p= 0.03). Conclusion: Primary tumor site is one of the main predictive factor of oncologic and functional outcomes after TPL.


Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE